TESSERA

Serial Number 88642455
Registration 6494020
700

Registration Progress

Application Filed
Oct 4, 2019
Under Examination
Aug 4, 2020
Approved for Publication
Jun 9, 2020
Published for Opposition
Jun 9, 2020
Registered
Sep 21, 2021

Trademark Image

TESSERA

Basic Information

Serial Number
88642455
Registration Number
6494020
Filing Date
October 4, 2019
Registration Date
September 21, 2021
Published for Opposition
June 9, 2020
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 21, 2021
Registration
Registered
Classes
001 005

Rights Holder

TESSERA THERAPEUTICS, INC.

03
Address
101 South Street, Suite 300
Somerville, MA 02143

Ownership History

Flagship VL58, Inc.

Original Applicant
03
Cambridge, MA

TESSERA THERAPEUTICS, INC.

New Owner Before Publication #1
03
CAMBRIDGE, MA

TESSERA THERAPEUTICS, INC.

Owner at Publication
03
CAMBRIDGE, MA

TESSERA THERAPEUTICS, INC.

Original Registrant
03
Somerville, MA

Legal Representation

Attorney
Christina M. Licursi, Esq.

USPTO Deadlines

Next Deadline
615 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210921)
Due Date
September 21, 2027
Grace Period Ends
March 21, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description Documents
Apr 6, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 6, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 6, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 6, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 6, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 21, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 17, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 16, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 13, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 3, 2021 IUAF S USE AMENDMENT FILED Loading...
Aug 13, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 3, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 3, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 1, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 1, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 1, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 4, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 9, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 9, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 20, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 29, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 28, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 28, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 28, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 28, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 20, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 20, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 20, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 11, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jan 9, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 9, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 9, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 9, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 12, 2019 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Nov 12, 2019 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Oct 8, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 001
Chemical and biological agents for scientific and research use, namely, for manipulating or modifying DNA; technology for enabling the engineering and modification of DNA, namely, molecular and cellular biology reagents and assays for the modification of cells and DNA
First Use Anywhere: May 27, 2021
First Use in Commerce: May 27, 2021
Class 005
Pharmaceutical preparations and therapeutic agents, namely, for gene therapy and DNA editing; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders
First Use Anywhere: May 27, 2021
First Use in Commerce: May 27, 2021

Classification

International Classes
001 005